DTaP-IPV vaccine

DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).^[1][2]

DTaP-IPV vaccine

DPT-IPV vaccine in Japan
Combination of
DTaP vaccine	Vaccine
Inactivated poliovirus vaccine	Vaccine
Clinical data
Trade names	Kinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others
Other names	diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
AHFS/Drugs.com	Kinrix Quadracel
Pregnancy category	AU: A
Routes of administration	Intramuscular injection
ATC code	J07CA02 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
CAS Number	1688606-07-6

It is also known as DTaP/IPV, dTaP/IPV, DTPa-IPV, or DPT-IPV.^[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.^[1]

Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline^[3] and Quadracel from Sanofi Pasteur.^[4]

Repevax is available in the UK.^[5][6]

In Japan, the formulation is called 四種混合(shishukongou - "mixture of 4"). Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available from Mitsubishi Tanabe Pharma named テトラビック ('Tetrabic').^[7][8] A previous product by Takeda Pharmaceutical Company has been withdrawn by the company.^[9]